Efficacy and safety of perampanel monotherapy in patients with focal-onset seizures with newly diagnosed epilepsy or recurrence of epilepsy after a period of remission: The open-label Study 342 (FREEDOM Study)

Disclaimer

This website is intended for healthcare professionals only. To proceed, please indicate your PRC (Professional Regulation Commission) number for verification purposes.

By clicking "Continue," you consent to the collection and use of your PRC number and any other personal data provided for the purpose of confirming your professional credentials and accessing restricted content in this site. Your data will be handled in accordance with our Data Privacy Policy and applicable data protection laws.

If you do not consent to these terms, please exit the site.

  • This field is for validation purposes and should be left unchanged.